SHR-1701 in Patients With Recurrent/Metastatic Scchn
NCT04650633
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
130
Enrollment
INDUSTRY
Sponsor class
Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG:
SHR-1701
Sponsor
Jiangsu HengRui Medicine Co., Ltd.